Diabetes Prevention Programs

CTAF

The Centers for Disease Control and Prevention (CDC) estimates that 29.1 million Americans have diabetes and 1.7 million adults are newly diagnosed with diabetes mellitus each year. The direct medical costs of diabetes were estimated to be $176 billion in 2012. Interventions to prevent diabetes have the potential to save the health care system substantial medical costs by reducing the incidence of diabetes and its associated complications. The Diabetes Prevention Program Trial (DPPT) demonstrated that the incidence of diabetes could be reduced using intensive diet and lifestyle counseling for individuals at very high risk for diabetes. Since publication of the trial results, many commercial programs have been developed to implement a scalable version of the DPPT intervention using fewer resources.

Intervention of interest: Diabetes prevention programs

Date of review: June 2016

Associated Meetings

The California Technology Assessment Forum (CTAF), a core program of the Institute for Clinical and Economic Review (ICER), held a public meeting in June 2016 to discuss the comparative effectiveness and value of diabetes prevention programs.


Key Dates

Associated Materials

03/03/2016

04/01/2016

05/09/2016

05/09/2016

06/06/2016

06/06/2016

06/06/2016

Public comments received on ICER’s Draft Evidence Report


06/06/2016

06/24/2016

06/24/2016

06/28/2016
Other Voting Results

07/25/2016

07/25/2016

01/17/2017

05/01/2017
Other Proven Best Choices